Silent atrial fibrillation: clinical management and perspectives.
Fiche publication
Date publication
mars 2020
Journal
Future cardiology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr LORGIS Luc
Tous les auteurs :
Guenancia C, Garnier F, Fichot M, Sagnard A, Laurent G, Lorgis L
Lien Pubmed
Résumé
Silent atrial fibrillation (AF) is an asymptomatic atrial arrhythmia that can be diagnosed by chance during a systematic electrocardiogram, an external Holter, or from implanted cardiac devices. There is a significant body of the literature around silent AF, yet it remains largely underdiagnosed in everyday clinical practice. Meanwhile, new diagnostic tools have significantly improved the detection of silent AF, creating a potential for mass screening via new technologies and the promise of a major step forward in e-health progress. However, it is not yet known whether silent AF is associated with the same thromboembolic risk as symptomatic AF, and whether these asymptomatic and often short-lasting episodes therefore require anticoagulation therapy and rhythm management.
Mots clés
Holter, anticoagulant therapy, atrial fibrillation, electrocardiogram, stroke
Référence
Future Cardiol. 2020 Mar;16(2):133-142